VectivBio Holding AG

NASDAQ:VECT   4:00:00 PM EDT
7.76
+0.23 (+3.05%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)315.21M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.29 Million
Adjusted EPS-$0.52
See more estimates
10-Day MA$7.68
50-Day MA$8.25
200-Day MA$6.50
See more pivots

VectivBio Holding AG Stock, NASDAQ:VECT

Aeschenvorstadt 36, Basel, Basel-Stadt (Basle Town) 4051
Switzerland
Phone: +41.615.51.30.30
Number of Employees: 32

Description

VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the development of treatments for severe rare conditions with significant unmet medical need. Its product pipeline include Apraglutide and CoMet. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland.